Seizures late in life may be an early sign of Alzheimer's disease
2013-07-09
(Press-News.org) Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA Neurology, a JAMA Network publication.
AD increases a patient's risk of risk of seizures, and patients with AD and seizure disorders have greater cognitive impairment, more rapid progression of symptoms and more severe neuronal loss at autopsy than those without seizures, according to the study background.
"Epileptic activity associated with Alzheimer disease (AD) deserves increased attention because it has a harmful impact on these patients, can easily go unrecognized and untreated and may reflect pathogenic processes that also contribute to other aspects of the illness," authors note in the study by Keith A. Vossel, M.D., M.Sc., of the Gladstone Institute of Neurological Disease, San Francisco, Calif., and colleagues.
The study included 54 patients with a diagnosis of aMCI plus epilepsy (n=12), AD plus epilepsy (n=35) and AD plus subclinical epileptiform activity (n=7).
Patients with aMCI who had epilepsy presented with symptoms of cognitive decline 6.8 years earlier than patients with aMCI who did not have epilepsy (64.3 vs. 71.1 years). Patients with AD who had epilepsy presented with cognitive decline 5.5 years earlier than patients with AD who did not have epilepsy (64.8 vs. 70.3 years), according to the results.
"Careful identification and treatment of epilepsy in such patients may improve their clinical course," the study concludes.
###
(JAMA Neurol. Published online July 8, 2013. doi:10.1001/jamaneurol.2013.136. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Authors made conflict of interest disclosures. This study was supported by National Institutes of Health grants and other sources. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2013-07-09
Cold Spring Harbor, NY – Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%. Novel therapies are urgently needed, as conventional and targeted approaches have not been successful and drug resistance is an increasing problem.
Previously it had been thought that poor penetration of the drugs into pancreas tumors was the main reason for treatment failure. But now a team of scientists led by Cold Spring Harbor Laboratory (CSHL) Professor David Tuveson M.D., Ph.D., shows there are other factors at work, too.
In ...
2013-07-09
University of Texas Medical Branch at Galveston researchers have discovered that hydrogen sulfide — the pungent-smelling gas produced by rotten eggs — is a key player in colon cancer metabolism, and a potential target for therapies for the disease.
In a paper appearing online this week in the Proceedings of the National Academy of Sciences, the UTMB scientists describe cell-culture and mouse experiments demonstrating that colon cancer cells produce large amounts of hydrogen sulfide, and depend on the compound for survival and growth.
"They love it and they need it," ...
2013-07-09
Scientists have found that key metabolites in blood – chemical 'fingerprints' left behind as a result of early molecular changes before birth or in infancy – could provide clues to a person's long-term overall health and rate of ageing in later life.
Published today in the International Journal of Epidemiology, the international study of twins led by King's College London highlights how a technique called metabolomic profiling has revealed a collection of 22 metabolites linked to ageing. One of these, linked to ageing traits such as lung function and bone mineral density, ...
2013-07-09
Boston – As the population gets older, and the baby boomers begin to enter their 60's and 70's, one might assume that the number of trips to the emergency department will also increase. This is contradicted by new research from Brigham and Women's Hospital (BWH), which shows that population aging will not cause the number of emergency department (ED) visits to increase between now and 2050. However, visits will become longer and hospitalizations will become more frequent. This research will appear in the July issue of Health Affairs.
"With US emergency care characterized ...
2013-07-09
CAMBRIDGE, MA -- A high level of air pollution, in the form of particulates produced by burning coal, significantly shortens the lives of people exposed to it, according to a unique new study of China co-authored by an MIT economist.
The research is based on long-term data compiled for the first time, and projects that the 500 million Chinese who live north of the Huai River are set to lose an aggregate 2.5 billion years of life expectancy due to the extensive use of coal to power boilers for heating throughout the region. Using a quasi-experimental method, the researchers ...
2013-07-09
DARIEN, IL – A new study suggests that CPAP therapy reduces nightmares in veterans with post-traumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).
Results show that the mean number of nightmares per week fell significantly with CPAP use, and reduced nightmare frequency after starting CPAP was best predicted by CPAP compliance.
"Patients with PTSD get more motivated to use CPAP once they get restful sleep without frequent nightmares, and their compliance improves" said principal investigator Sadeka Tamanna, MD, MPH, medical director of the Sleep Disorders ...
2013-07-09
(Santa Barbara, California) –– The North Pole isn't the only place on Earth affected by slight increases in temperature. Until recently, scientific thinking used to posit that tropical forests, which already exist in warm climates, may not be impacted much by climate change. But a new study conducted by UC Santa Barbara's National Center for Ecological Analysis and Synthesis (NCEAS) shows that to be erroneous. In fact, the results indicate that tropical forests are producing more flowers in response to only slight increases in temperature. The findings were published online ...
2013-07-09
MENLO PARK, Calif.—July 8, 2013—A hallmark of neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's is that by the time symptoms appear, significant brain damage has already occurred—and currently there are no treatments that can reverse it. A team of SRI International researchers has demonstrated that measurements of electrical activity in the brains of mouse models of Huntington's disease could indicate the presence of disease before the onset of major symptoms. The findings, "Longitudinal Analysis of the Electroencephalogram and Sleep Phenotype ...
2013-07-09
Defying 30 mph gusts and temperatures down to minus 22 F, NASA's new polar rover recently demonstrated in Greenland that it could operate completely autonomously in one of Earth's harshest environments.
The robot known as GROVER, which stands for both Greenland Rover and Goddard Remotely Operated Vehicle for Exploration and Research, was designed by teams of students attending engineering boot camps at Goddard in the summers of 2010 and 2011. Built to carry a ground-penetrating radar to analyze layers of snow and ice, the rover was later transferred to Boise State University ...
2013-07-09
CHAPEL HILL, N.C. - The tyrosine kinase MerTK plays a prominent role in the body's immune response. MerTK signaling helps "calm" the body's first line of immunity, the macrophage, while it performs the routine duties - clearing cells that die and healing damaged tissue.
New evidence by a University of North Carolina-led team published online on July 8 by the Journal of Clinical Investigation shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize. The study, led ...
LAST 30 PRESS RELEASES:
[Press-News.org] Seizures late in life may be an early sign of Alzheimer's disease
